ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study
5 January 2018
ReCor Medical announced today randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study. RADIANCE-HTN, ReCor's study of its
Thank you for your interest in publishing press release with pulp & paper. Our client success team member will get in touch with you shortly to take this ahead. While you're here, check out our informative and insightful press releases. Happy Surfing!
Regards,
Client Success Team (CRM),
Successfully repored......
Regards,
Client Success Team (CRM),
5 January 2018
ReCor Medical announced today randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study. RADIANCE-HTN, ReCor's study of its
